Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission
Conditions
- Acute Lymphoblastic Leukemia
Interventions
- BEHAVIORAL: Behavioral Intervention
- BEHAVIORAL: Compliance Monitoring
- OTHER: Laboratory Biomarker Analysis
- DRUG: Mercaptopurine
- OTHER: Questionnaire Administration
- PROCEDURE: Standard Follow-Up Care
Sponsor
Children's Oncology Group
Collaborators